KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $28.2 million.

  • Biolife Solutions' Operating Expenses rose 2910.27% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.2 million, marking a year-over-year increase of 15506.94%. This contributed to the annual value of $89.4 million for FY2024, which is 998.24% down from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Operating Expenses is $28.2 million, which was up 2910.27% from $42.1 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Operating Expenses high stood at $117.1 million for Q2 2022, and its period low was -$131.6 million during Q4 2022.
  • For the 5-year period, Biolife Solutions' Operating Expenses averaged around $28.1 million, with its median value being $35.8 million (2021).
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 26207.98% in 2021, then crashed by 33598.35% in 2022.
  • Quarter analysis of 5 years shows Biolife Solutions' Operating Expenses stood at $55.8 million in 2021, then crashed by 335.98% to -$131.6 million in 2022, then skyrocketed by 86.75% to -$17.4 million in 2023, then soared by 242.41% to $24.8 million in 2024, then increased by 13.42% to $28.2 million in 2025.
  • Its Operating Expenses stands at $28.2 million for Q3 2025, versus $42.1 million for Q2 2025 and $25.2 million for Q1 2025.